Maintaining the neuronal phenotype after injury in the adult CNS. Neurotrophic factors, axonal growth substrates, and gene therapy
- PMID: 7576305
- DOI: 10.1007/BF02740673
Maintaining the neuronal phenotype after injury in the adult CNS. Neurotrophic factors, axonal growth substrates, and gene therapy
Abstract
Multiple genetic and epigenetic events determine neuronal phenotype during nervous system development. After the mature mammalian neuronal phenotype has been determined it is usually static for the remainder of life, unless an injury or degenerative event occurs. Injured neurons may suffer one of three potential fates: death, persistent atrophy, or recovery. The ability of an injured adult neuron to recover from injury in adulthood may be determined by events that also influence neuronal phenotype during development, including expression of growth-related genes and responsiveness to survival and growth signals in the environment. The latter signals include neurotrophic factors and substrate molecules that promote neurite growth. Several adult CNS regions exhibit neurotrophic-factor responsiveness, including the basal forebrain, entorhinal cortex, hippocampus, thalamus, brainstem, and spinal cord. The specificity of neurotrophic-factor responsiveness in these regions parallels patterns observed during development. In addition, neurons of several CNS regions extend neurites after injury when presented with growth-promoting substrates. When both neurotrophic factors and growth-promoting substrates are provided to adult rats that have undergone bilateral fimbria-fornix lesions, then partial morphological and behavioral recovery can be induced. Gene therapy is one useful tool for providing these substances. Thus, the mature CNS remains robustly responsive to signals that shape nervous system development, and is highly plastic when stimulated by appropriate cues.
Similar articles
-
Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat.Exp Neurol. 1997 Dec;148(2):475-94. doi: 10.1006/exnr.1997.6705. Exp Neurol. 1997. PMID: 9417827
-
Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration.Gene Ther. 1996 Apr;3(4):305-14. Gene Ther. 1996. PMID: 8732162
-
Bridging grafts and transient nerve growth factor infusions promote long-term central nervous system neuronal rescue and partial functional recovery.Proc Natl Acad Sci U S A. 1995 May 9;92(10):4621-5. doi: 10.1073/pnas.92.10.4621. Proc Natl Acad Sci U S A. 1995. PMID: 7753852 Free PMC article.
-
Grafts, growth factors and grafts that make growth factors.Prog Brain Res. 1990;82:55-66. doi: 10.1016/s0079-6123(08)62590-x. Prog Brain Res. 1990. PMID: 2290958 Review. No abstract available.
-
Neurotrophic factors and gene therapy in spinal cord injury.Neurorehabil Neural Repair. 2000;14(4):265-75. doi: 10.1177/154596830001400403. Neurorehabil Neural Repair. 2000. PMID: 11402877 Review.
Cited by
-
Inhibition of retinal ganglion cell axonal outgrowth through the Amino-Nogo-A signaling pathway.Neurochem Res. 2013 Jul;38(7):1365-74. doi: 10.1007/s11064-013-1032-1. Epub 2013 Apr 12. Neurochem Res. 2013. PMID: 23579387
-
Neural stem cells improve memory in an inducible mouse model of neuronal loss.J Neurosci. 2007 Oct 31;27(44):11925-33. doi: 10.1523/JNEUROSCI.1627-07.2007. J Neurosci. 2007. PMID: 17978032 Free PMC article.
-
Ex vivo infection of human embryonic spinal cord neurons prior to transplantation into adult mouse cord.BMC Neurosci. 2010 May 29;11:65. doi: 10.1186/1471-2202-11-65. BMC Neurosci. 2010. PMID: 20509957 Free PMC article.
-
Preparation of brain-derived neurotrophic factor- and neurotrophin-3-secreting Schwann cells by infection with a retroviral vector.J Mol Neurosci. 1998 Apr;10(2):143-60. doi: 10.1007/BF02737125. J Mol Neurosci. 1998. PMID: 9699155
-
Nerve Growth Factor Is Responsible for Exercise-Induced Recovery of Septohippocampal Cholinergic Structure and Function.Front Neurosci. 2018 Nov 1;12:773. doi: 10.3389/fnins.2018.00773. eCollection 2018. Front Neurosci. 2018. PMID: 30443202 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical